Deputy Minister of Health Do Xuan Tuyen said all three vaccines developed by Vietnam’s companies, including Nanocovax, Covivac and ARCT-154, are under clinical trials.
After an emergency meeting, the National Ethics Council agreed to test the locally-made Covid-19 vaccine Nanocovax on 13,000 volunteers. This third phase trial will be completed in mid-August.
The test of locally-made Nanocovax vaccine has yielded positive signs. In case of emergency approval, Vietnam would be able to produce 100 million doses per year.
Soon after the phase 3 trial, Vietnam may consider emergency licensing for Nanocovax, a made-in-Vietnam Covid-19 vaccine.
Vietnam has completed the first-dose vaccination of 560 volunteers who participated in the Phase 2 trial of Nanocovax's Covid-19 vaccine,
Three volunteers getting the first shot of the 25mcg dose of Nanocovax, the first Vietnamese COVID-19 vaccine to be tested on humans, last December received the second on January 14.
The Institute of Vaccines and Medical Biologicals (IVAC), based in central Khanh Hoa province, has proposed the Ministry of Health allow human trials of its COVID-19 vaccine to begin in January, two months ahead of schedule.
A further 17 people out of the 60 volunteers participating in the first phase of human trials to develop Nanocovax, a locally-produced novel coronavirus (COVID-19) vaccine, received their vaccine shots on December 22 at the Military Medical Academy.